Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Intangibles (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Intangibles for 16 consecutive years, with $79.5 million as the latest value for Q2 2025.

  • On a quarterly basis, Intangibles changed N/A to $79.5 million in Q2 2025 year-over-year; TTM through Jun 2025 was $79.5 million, a N/A change, with the full-year FY2024 number at $70.0 million, down 4.47% from a year prior.
  • Intangibles was $79.5 million for Q2 2025 at Acadia Healthcare Company, up from $70.0 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $79.5 million in Q2 2025 to a low of $69.4 million in Q3 2021.
  • A 5-year average of $73.4 million and a median of $73.3 million in 2023 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: dropped 22.95% in 2021, then rose 9.45% in 2022.
  • Acadia Healthcare Company's Intangibles stood at $70.1 million in 2021, then increased by 8.41% to $76.0 million in 2022, then fell by 3.63% to $73.3 million in 2023, then dropped by 4.47% to $70.0 million in 2024, then grew by 13.52% to $79.5 million in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Intangibles are $79.5 million (Q2 2025), $70.0 million (Q4 2024), and $73.3 million (Q4 2023).